70 related articles for article (PubMed ID: 2396540)
1. Characterization of a protein product of human malignant glial tumors that induces microvascular permeability.
Criscuolo GR; Merrill MJ; Oldfield EH
Adv Neurol; 1990; 52():469-74. PubMed ID: 2396540
[No Abstract] [Full Text] [Related]
2. Further characterization of malignant glioma-derived vascular permeability factor.
Criscuolo GR; Merrill MJ; Oldfield EH
J Neurosurg; 1988 Aug; 69(2):254-62. PubMed ID: 3134521
[TBL] [Abstract][Full Text] [Related]
3. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
[TBL] [Abstract][Full Text] [Related]
5. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
Bruce JN; Criscuolo GR; Merrill MJ; Moquin RR; Blacklock JB; Oldfield EH
J Neurosurg; 1987 Dec; 67(6):880-4. PubMed ID: 3681425
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
Sioussat TM; Dvorak HF; Brock TA; Senger DR
Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
[TBL] [Abstract][Full Text] [Related]
7. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
Criscuolo GR; Lelkes PI; Rotrosen D; Oldfield EH
J Neurosurg; 1989 Dec; 71(6):884-91. PubMed ID: 2585081
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and microvascular permeability.
Bates DO; Lodwick D; Williams B
Microcirculation; 1999 Jun; 6(2):83-96. PubMed ID: 10466111
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor.
Gossmann A; Helbich TH; Mesiano S; Shames DM; Wendland MF; Roberts TP; Ferrara N; Jaffe RB; Brasch RC
Am J Obstet Gynecol; 2000 Oct; 183(4):956-63. PubMed ID: 11035346
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
13. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
15. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
19. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
20. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
